Cargando…
Antibody response to inactivated COVID‐19 vaccine in patients with type 2 diabetes mellitus after the booster immunization
BACKGROUND: The immunogenicity of booster inactivated COVID‐19 vaccines in patients with type 2 diabetes mellitus (T2DM) has remained unclear. Our study aims to investigate the antibody response to inactivated COVID‐19 vaccine following booster vaccination in patients with T2DM. METHODS: A total of...
Autores principales: | Li, Haolong, Wang, Yao, Li, Xiaomeng, Wang, Siyu, Feng, Xinxin, Xiao, Xinhua, Li, Yongzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667667/ https://www.ncbi.nlm.nih.gov/pubmed/37518861 http://dx.doi.org/10.1111/1753-0407.13448 |
Ejemplares similares
-
Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023) -
Vitamin D receptor methylation attenuates the association between physical activity and type 2 diabetes mellitus: A case‐control study
por: Yu, Songcheng, et al.
Publicado: (2021) -
Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases
por: Liu, Yongmei, et al.
Publicado: (2023) -
Relationship between creatinine to body weight ratios and diabetes mellitus: A Chinese cohort study
por: Chen, Zhuangsen, et al.
Publicado: (2022) -
Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus
por: Liu, Hongyan, et al.
Publicado: (2022)